Purine and pyrimidine pathways as targets in Plasmodium falciparum.
暂无分享,去创建一个
V. Schramm | M. Cassera | María Belén Cassera | Vern L Schramm | Yong Zhang | Keith Z Hazleton | Yong Zhang | Keith Z. Hazleton
[1] D. Hammond,et al. Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. , 1985, Molecular and biochemical parasitology.
[2] R. Furneaux,et al. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase. , 1998, Biochemistry.
[3] J. Hyde. DRUG-RESISTANT MALARIA , 1981, The Lancet.
[4] V. Schramm,et al. Synthesis of 5'-methylthio coformycins: specific inhibitors for malarial adenosine deaminase. , 2007, Journal of the American Chemical Society.
[5] Amy C Anderson,et al. Targeting DHFR in parasitic protozoa. , 2005, Drug discovery today.
[6] G. Evans,et al. Purine-less Death in Plasmodium falciparumInduced by Immucillin-H, a Transition State Analogue of Purine Nucleoside Phosphorylase* , 2002, The Journal of Biological Chemistry.
[7] Hee-Yong Kim,et al. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase. , 1989, The Journal of biological chemistry.
[8] R. Christopherson,et al. Inhibitors of de novo nucleotide biosynthesis as drugs. , 2002, Accounts of chemical research.
[9] R. Davis,et al. Cloning and expression in Escherichia coli of a hypoxanthine-guanine phosphoribosyltransferase-encoding cDNA from Plasmodium falciparum. , 1990, Gene.
[10] K. Anderson,et al. Probing the role of parasite-specific, distant structural regions on communication and catalysis in the bifunctional thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum. , 2008, Biochemistry.
[11] Z. Ram,et al. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors. , 1995, Cancer research.
[12] D. Warhurst,et al. Resistance to Antifolates in Plasmodium Falciparum, the Causative Agent of Tropical Malaria , 2002, Science progress.
[13] J Mitchell Guss,et al. Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum. , 2008, Biochemistry.
[14] T. Traut,et al. Intrinsic Activity and Stability of Bifunctional Human UMP Synthase and Its Two Separate Catalytic Domains, Orotate Phosphoribosyltransferase and Orotidine-5′-phosphate Decarboxylase (*) , 1996, The Journal of Biological Chemistry.
[15] R. Anand,et al. Unique kinetic mechanism of Plasmodium falciparum adenylosuccinate synthetase. , 2004, Molecular and biochemical parasitology.
[16] Y. Kitade,et al. Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery , 2009, Parasitology.
[17] A. Hudson,et al. Atovaquone - a novel broad-spectrum anti-infective drug. , 1993, Parasitology today.
[18] Timo Heikkilae,et al. Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase. , 2007, Journal of medicinal chemistry.
[19] V. Schramm,et al. Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction. , 1993, Biochemistry.
[20] D. V. Vander Jagt,et al. Properties and substrate specificity of a purine phosphoribosyltransferase from the human malaria parasite, Plasmodium falciparum. , 1988, Molecular and biochemical parasitology.
[21] S. Krungkrai,et al. Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile. , 2004, Molecular and biochemical parasitology.
[22] P. Rathod,et al. High-throughput Screening for Potent and Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase* , 2005, Journal of Biological Chemistry.
[23] Mercaptan and dicarboxylate inhibitors of hamster dihydroorotase. , 1989, Biochemistry.
[24] D. Wirth,et al. Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase* , 2008, Journal of Biological Chemistry.
[25] R. Wolfenden,et al. A proficient enzyme. , 1995, Science.
[26] M. V. Flores,et al. Inhibition of Plasmodium falciparum Proliferationin Vitro by Ribozymes* , 1997, The Journal of Biological Chemistry.
[27] L. Naesens,et al. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics. , 2009, Journal of medicinal chemistry.
[28] T Judit,et al. Keeping Uracil Out of DNA: Physiological Role, Structure and Catalytic Mechanism of dUTPases , 2008 .
[29] V. Schramm,et al. Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases. , 2004, Biochemistry.
[30] M. Markert,et al. Purine nucleoside phosphorylase deficiency , 2020, Atlas of Inherited Metabolic Diseases.
[31] H. D. de Koning,et al. Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. , 2005, FEMS microbiology reviews.
[32] V. Schramm,et al. Structural and metabolic specificity of methylthiocoformycin for malarial adenosine deaminases. , 2009, Biochemistry.
[33] H. Mitsuya,et al. Potentiation of The Anti-HIV Activity of Zalcitabine and Lamivudine by a CTP Synthase Inhibitor, 3-Deazauridine , 2000, Nucleosides, nucleotides & nucleic acids.
[34] Yongyuth Yuthavong,et al. Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. , 2004, Journal of medicinal chemistry.
[35] I. Gilbert,et al. Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target. , 2005, Journal of medicinal chemistry.
[36] K. K. Seymour,et al. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. , 1994, Biochemistry.
[37] P. Rathod,et al. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. , 1997, Experimental parasitology.
[38] G. F. Ruda,et al. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase. , 2006, Journal of medicinal chemistry.
[39] A. Vaidya,et al. Atovaquone, a Broad Spectrum Antiparasitic Drug, Collapses Mitochondrial Membrane Potential in a Malarial Parasite* , 1997, The Journal of Biological Chemistry.
[40] cis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1 H)-one , a potent inhibitor of mammalian dihydroorotase. , 1988, Journal of medicinal chemistry.
[41] R. Barker,et al. Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. E. Hyde,et al. Drug‐resistant malaria − an insight , 2007, The FEBS journal.
[43] Kellen L. Olszewski,et al. Host-parasite interactions revealed by Plasmodium falciparum metabolomics. , 2009, Cell host & microbe.
[44] R. Anand,et al. Plasmodium falciparum hypoxanthine guanine phosphoribosyltransferase , 2005, The FEBS journal.
[45] A. Jakubowski,et al. Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells. , 1979, Cancer research.
[46] C. Grubmeyer,et al. Transition state structure of Salmonella typhimurium orotate phosphoribosyltransferase. , 1996, Biochemistry.
[47] A. Breckenridge,et al. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs , 1995, Antimicrobial agents and chemotherapy.
[48] M. Davies,et al. Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases. , 2009, Journal of medicinal chemistry.
[49] Joanne M. Morrisey,et al. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.
[50] Theresa M. Lyons,et al. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria. , 2009, ACS chemical biology.
[51] R. Williamson,et al. Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. , 1996, Transplantation proceedings.
[52] H. Webster,et al. Expression of human malaria parasite purine nucleoside phosphorylase in host enzyme-deficient erythrocyte culture. Enzyme characterization and identification of novel inhibitors. , 1986, The Journal of biological chemistry.
[53] M. E. Jones,et al. Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. , 1980, Annual review of biochemistry.
[54] V. Schramm,et al. Erythrocytic Adenosine Monophosphate as an Alternative Purine Source in Plasmodium falciparum* , 2008, Journal of Biological Chemistry.
[55] I. Gilbert,et al. Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase. , 2009, European journal of medicinal chemistry.
[56] V. Schramm,et al. Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases. , 2007, Journal of the American Chemical Society.
[57] M. Mather,et al. Mitochondrial evolution and functions in malaria parasites. , 2009, Annual review of microbiology.
[58] D. González-Pacanowska,et al. Kinetic properties and specificity of trimeric Plasmodium falciparum and human dUTPases. , 2010, Biochimie.
[59] V. Schramm. Enzymatic transition states and transition state analog design. , 1998, Annual review of biochemistry.
[60] R. Furneaux,et al. The 2.0 Å structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor , 1999, Nature Structural Biology.
[61] W. O'Sullivan,et al. Pyrimidine de novo synthesis during the life cycle of the intraerythrocytic stage of Plasmodium falciparum. , 1984, The Journal of parasitology.
[62] Kami Kim,et al. Transition State Analogue Inhibitors of Purine Nucleoside Phosphorylase from Plasmodium falciparum * , 2002, The Journal of Biological Chemistry.
[63] H. Webster,et al. Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo. , 1984, Advances in experimental medicine and biology.
[64] H. Levine,et al. Inhibition of orotidine-5'-phosphate decarboxylase by 1-(5'-phospho-beta-d-ribofuranosyl)barbituric acid, 6-azauridine 5'-phosphate, and uridine 5'-phosphate. , 1980, Biochemistry.
[65] J. Hyde. Targeting purine and pyrimidine metabolism in human apicomplexan parasites. , 2007, Current drug targets.
[66] W. O'Sullivan,et al. In vitro inhibition of Plasmodium falciparum by pyrazofurin, an inhibitor of pyrimidine biosynthesis de novo. , 1986, Molecular and biochemical parasitology.
[67] S. Hay,et al. The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.
[68] V. Schramm. Enzymatic transition state poise and transition state analogues. , 2003, Accounts of chemical research.
[69] V. Schramm,et al. Transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases. , 2009, Journal of the American Chemical Society.
[70] G. Evans,et al. Femtomolar Transition State Analogue Inhibitors of 5′-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase from Escherichia coli* , 2005, Journal of Biological Chemistry.
[71] B. Emmerson,et al. Purification and characterization of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase and comparison with the human enzyme. , 1999, Molecular and biochemical parasitology.
[72] G. Evans,et al. Achieving the Ultimate Physiological Goal in Transition State Analogue Inhibitors for Purine Nucleoside Phosphorylase* , 2003, Journal of Biological Chemistry.
[73] S. Krungkrai,et al. Dihydroorotase of human malarial parasite Plasmodium falciparum differs from host enzyme. , 2008, Biochemical and biophysical research communications.
[74] J. Savickienė,et al. 3-Deazauridine triggers dose-dependent apoptosis in myeloid leukemia cells and enhances retinoic acid-induced granulocytic differentiation of HL-60 cells. , 2003, The international journal of biochemistry & cell biology.
[75] G. Evans,et al. Targeting a Novel Plasmodium falciparum Purine Recycling Pathway with Specific Immucillins* , 2005, Journal of Biological Chemistry.
[76] P. Rathod,et al. Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro , 1989, Antimicrobial Agents and Chemotherapy.
[77] I. Gilbert,et al. dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitors. , 2005, Structure.
[78] A. E. Yeo,et al. Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[79] R. Furneaux,et al. The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor. , 1999, Biochemistry.
[80] P. Rathod,et al. Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum , 1994, Antimicrobial Agents and Chemotherapy.
[81] Yan Li,et al. A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity. , 2007, Journal of medicinal chemistry.
[82] G. Wahl,et al. Mechanism of action for leflunomide in rheumatoid arthritis. , 1999, Clinical immunology.
[83] Kiaran Kirk,et al. The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum , 2005, Genome Biology.
[84] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[85] A. Nzila,et al. Inhibitors of de novo folate enzymes in Plasmodium falciparum. , 2006, Drug discovery today.
[86] R. Wolfenden,et al. Transition State Analogues for Enzyme Catalysis , 1969, Nature.
[87] Jan Balzarini,et al. Rational design of 5'-thiourea-substituted alpha-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacterial growth. , 2007, Journal of medicinal chemistry.
[88] M. Murthy,et al. Crystal structure of fully ligated adenylosuccinate synthetase from Plasmodium falciparum. , 2004, Journal of molecular biology.
[89] H. Balaram,et al. Evidence for multiple active states of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase. , 2000, Biochemical and biophysical research communications.
[90] P. Rathod,et al. Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. , 1982, Molecular and biochemical parasitology.
[91] P. Morand,et al. Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound (*) , 1995, The Journal of Biological Chemistry.
[92] Y. Kitade,et al. Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase. , 2008, Journal of biochemistry.
[93] D. Santi,et al. Thymidylate synthase-dihydrofolate reductase in protozoa. , 1990, Experimental parasitology.
[94] H. Munier-Lehmann,et al. Synthesis and Biological Evaluation of Bicyclic Nucleosides as Inhibitors of M. tuberculosis Thymidylate Kinase , 2006, ChemMedChem.
[95] G. Evans,et al. Plasmodium falciparum Purine Nucleoside Phosphorylase , 2004, Journal of Biological Chemistry.
[96] E. Poduch,et al. Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase. , 2008, Journal of medicinal chemistry.
[97] W. O'Sullivan,et al. Molecular cloning and characterization of the Plasmodium falciparum cytidine triphosphate synthetase gene. , 1998, Biochimica et biophysica acta.
[98] G. Stark,et al. Coordinate overproduction of orotate phosphoribosyltransferase and orotidine-5'-phosphate decarboxylase in hamster cells resistant to pyrazofurin and 6-azauridine. , 1979, The Journal of biological chemistry.
[99] H. Balaram,et al. Kinetic and biochemical characterization of Plasmodium falciparum GMP synthetase. , 2008, The Biochemical journal.
[100] M. V. Flores,et al. Characterisation of the carbamoyl phosphate synthetase gene from Plasmodium falciparum. , 1994, Molecular and biochemical parasitology.
[101] L. M. Alvarez-Salas,et al. Nucleic acids as therapeutic agents. , 2008, Current topics in medicinal chemistry.
[102] R. Furneaux,et al. Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases , 1999, Nature Structural Biology.
[103] V. Barton,et al. The Molecular Mechanism of Action of Artemisinin—The Debate Continues , 2010, Molecules.
[104] W. O'Sullivan,et al. Functional expression of the gene encoding cytidine triphosphate synthetase from Plasmodium falciparum which contains two novel sequences that are potential antimalarial targets. , 2005, Molecular and biochemical parasitology.
[105] P. Rathod,et al. Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum. , 2008, Journal of medicinal chemistry.
[106] Increased levels of UMP synthase protein and mRNA in pyrazofurin-resistant rat hepatoma cells. , 1983, The Journal of biological chemistry.
[107] D. Warhurst,et al. Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210. , 2001, Molecular and biochemical parasitology.
[108] V. Schramm. Enzymatic Transition State Theory and Transition State Analogue Design* , 2007, Journal of Biological Chemistry.
[109] V. Schramm,et al. Enzymatic transition states and transition state analogues. , 2005, Current opinion in structural biology.
[110] H. Balaram,et al. Elucidation of the substrate specificity, kinetic and catalytic mechanism of adenylosuccinate lyase from Plasmodium falciparum. , 2009, Biochimica et biophysica acta.
[111] D. L. Jagt,et al. In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism , 1990, Antimicrobial Agents and Chemotherapy.
[112] Yongyuth Yuthavong,et al. Insights into antifolate resistance from malarial DHFR-TS structures , 2003, Nature Structural Biology.
[113] Effects of Substrate Binding Determinants in the Transition State for Orotidine 5′-Monophosphate Decarboxylase , 1998 .
[114] G. Evans,et al. Over-the-barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase. , 2003, Biochemistry.
[115] M. Fry,et al. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). , 1992, Biochemical pharmacology.
[116] Richard Wolfenden,et al. Catalytic proficiency: the unusual case of OMP decarboxylase. , 2002, Annual review of biochemistry.
[117] W. Milhous,et al. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists. , 1993, The American journal of tropical medicine and hygiene.
[118] L. Hedstrom,et al. Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase. , 2001, Biochemistry.
[119] T. Stewart,et al. Redesigned and chemically-modified hammerhead ribozymes with improved activity and serum stability , 2004, BMC chemical biology.
[120] H. Kim,et al. Mammalian dihydroorotase: nucleotide sequence, peptide sequences, and evolution of the dihydroorotase domain of the multifunctional protein CAD. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[121] J. Grem,et al. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells. , 1992, Biochemical pharmacology.
[122] M. E. Hodgson,et al. Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families. , 1997, American journal of human genetics.
[123] M. C. Wang,et al. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine. , 1974, Cancer research.
[124] V. Schramm,et al. Transport of purines and purine salvage pathway inhibitors by the Plasmodium falciparum equilibrative nucleoside transporter PfENT1. , 2010, Molecular and biochemical parasitology.
[125] Yongyuth Yuthavong,et al. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities. , 2004, Journal of medicinal chemistry.
[126] Bing Zhou,et al. Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies , 2010, Molecules.
[127] P. Trackman,et al. Methionine synthesis from 5'-S-Methylthioadenosine. Resolution of enzyme activities and identification of 1-phospho-5-S methylthioribulose. , 1983, The Journal of biological chemistry.
[128] S. Krungkrai,et al. Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase. , 1992, Biochemical pharmacology.